Yahoo
Jakarta - Delayed Quote IDR

PT Medikaloka Hermina Tbk (HEAL.JK)

468.00 -28.00 (-5.65%)
At close: 4:11:00 PM GMT+7
View in AlphaSpace Currency in IDR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
7,368,562,000
7,133,538,000
6,717,179,000
5,784,084,000
4,901,810,000
Cost of Revenue
4,908,071,000
4,719,187,000
4,281,079,000
3,727,478,000
3,193,422,000
Gross Profit
2,460,491,000
2,414,351,000
2,436,100,000
2,056,606,000
1,708,388,000
Operating Expense
1,582,208,000
1,472,995,000
1,399,367,000
1,275,909,000
1,192,032,000
Operating Income
878,283,000
941,356,000
1,036,733,000
780,697,000
516,356,000
Net Non Operating Interest Income Expense
-218,618,000
-212,159,000
-151,070,000
-107,582,000
-107,285,000
Pretax Income
686,868,000
754,882,000
907,149,000
710,393,000
480,088,000
Tax Provision
198,638,000
205,918,000
218,020,000
151,109,000
101,315,000
Net Income Common Stockholders
376,848,000
429,547,000
535,942,000
437,346,000
298,596,000
Diluted NI Available to Com Stockholders
376,848,000
429,547,000
535,942,000
437,346,000
298,596,000
Basic EPS
24.57
28.40
36.11
30.16
20.64
Diluted EPS
24.57
28.40
36.11
29.73
20.29
Basic Average Shares
15,307,698.01
15,124,332.26
14,841,909.76
14,500,933.03
14,464,460.29
Diluted Average Shares
15,307,698.01
15,124,332.26
14,841,909.76
14,713,048.84
14,714,412.34
Total Operating Income as Reported
905,486,000
967,041,000
1,058,219,000
817,975,000
587,373,000
Total Expenses
6,490,279,000
6,192,182,000
5,680,446,000
5,003,387,000
4,385,454,000
Net Income from Continuing & Discontinued Operation
376,848,000
429,547,000
535,942,000
437,346,000
298,596,000
Normalized Income
377,173,549.22
430,632,009.69
536,918,169.04
436,948,419.48
299,046,499.46
Interest Income
13,954,000
26,281,000
28,029,000
31,978,000
32,548,000
Interest Expense
232,572,000
238,440,000
179,099,000
139,560,000
139,833,000
Net Interest Income
-218,618,000
-212,159,000
-151,070,000
-107,582,000
-107,285,000
EBIT
919,440,000
993,322,000
1,086,248,000
849,953,000
619,921,000
EBITDA
1,206,228,000
1,272,665,000
1,345,588,000
1,100,749,000
812,545,000
Reconciled Cost of Revenue
4,908,071,000
4,719,187,000
4,281,079,000
3,727,478,000
3,193,422,000
Reconciled Depreciation
286,788,000
279,343,000
259,340,000
250,796,000
192,624,000
Net Income from Continuing Operation Net Minority Interest
376,848,000
429,547,000
535,942,000
437,346,000
298,596,000
Total Unusual Items Excluding Goodwill
-458,000
-1,492,000
-1,285,000
505,000
-571,000
Total Unusual Items
-458,000
-1,492,000
-1,285,000
505,000
-571,000
Normalized EBITDA
1,206,686,000
1,274,157,000
1,346,873,000
1,100,244,000
813,116,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-132,450.78
-406,990.31
-308,830.96
107,419.48
-120,500.54
12/31/2022 - 5/17/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: